{
  "docId": "019de076-e0bc-7319-b2fa-5eeb46bcf895",
  "docSlug": "439c1d555948cf75a9b0a41f96565740",
  "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
  "authorId": "matinas-biopharma",
  "authorName": "Matinas BioPharma",
  "documentKindSlug": "deck",
  "documentKindLabel": "Deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 3,
  "pageCount": 29,
  "prevPage": 2,
  "nextPage": 4,
  "slideType": "thesis_headline",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 2,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-e0bc-7319-b2fa-5eeb46bcf895/3",
  "deckHref": "/decks/019de076-e0bc-7319-b2fa-5eeb46bcf895",
  "deckJsonHref": "/decks/019de076-e0bc-7319-b2fa-5eeb46bcf895.json",
  "deckAnchorHref": "/decks/019de076-e0bc-7319-b2fa-5eeb46bcf895#slide-3",
  "components": [
    {
      "bbox": {
        "h": 0.13,
        "w": 0.08,
        "x": 0.33,
        "y": 0.17
      },
      "kind": "image",
      "text": "Lipid Nanocrystals (LNCs) graphic",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "eb8dc26f-e602-4bf9-9b0f-ebcc4b0a09f6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.45,
        "x": 0.045,
        "y": 0.56
      },
      "kind": "list",
      "text": "Oral Amphotericin B - without nephrotoxicity; Phase 3-ready; Provides effective longer-term fungicidal stepdown therapy; 12 years of exclusivity",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7f0d7037-f6c1-42f9-8a43-46a844a5150e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.45,
        "x": 0.55,
        "y": 0.56
      },
      "kind": "list",
      "text": "Current efforts expanding LNC application beyond small molecules; Expanding primary therapeutic applications from infectious disease to inflammation and cancer",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a9153aa0-5d43-481e-867c-72a4fd339ca5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.13,
        "w": 0.25,
        "x": 0.468,
        "y": 0.185
      },
      "kind": "list",
      "text": "Intracellular delivery; Oral administration; Less toxicity; Targeting beyond the liver",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bc5316aa-b357-4a6d-8a87-ef3753f24a0e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.68,
        "x": 0.16,
        "y": 0.38
      },
      "kind": "paragraph",
      "text": "MAT2203 Clinical Validation of LNC Capabilities",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a2fee8ff-bb34-42f7-a070-dc8c8c02e074",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.75,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "title",
      "text": "Matinas Investment Thesis: LNC Delivery Unlocks Therapeutic Value",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "99eed996-a7d4-479e-a461-0c82a62e1f12",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Thesis archetype",
      "slug": "thesis-archetype",
      "agent": null,
      "layer": "slide",
      "matchId": "8b374bdb-ac27-4a5c-a161-687783dd24a3",
      "evidence": "Matinas Investment Thesis: LNC Delivery Unlocks Therapeutic Value",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 3,
      "from": 3,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "b23670eb-1c8c-4cef-9664-274fee134932",
      "evidence": "Slide 3 presents the investment thesis for Matinas BioPharma's LNC platform.",
      "position": 1,
      "objective": "Why is Matinas BioPharma's LNC platform important?",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.5,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}